 |
PDBsum entry 3k3b
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Motor protein
|
PDB id
|
|
|
|
3k3b
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Motor protein
|
 |
|
Title:
|
 |
Co-crystal structure of the human kinesin eg5 with a novel tetrahydro- beta-carboline
|
|
Structure:
|
 |
Kinesin-like protein kif11. Chain: a, b. Fragment: unp residues 1-368. Synonym: kinesin-related motor protein eg5, kinesin-like spindle protein hksp, thyroid receptor-interacting protein 5, trip-5, kinesin-like protein 1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: kif11, eg5, knsl1, trip5. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.208
|
R-free:
|
0.243
|
|
|
Authors:
|
 |
D.E.Bussiere,C.Bellamacina,V.Le
|
|
Key ref:
|
 |
P.A.Barsanti
et al.
(2010).
The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.
Bioorg Med Chem Lett,
20,
157-160.
PubMed id:
|
 |
|
Date:
|
 |
|
02-Oct-09
|
Release date:
|
15-Dec-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P52732
(KIF11_HUMAN) -
Kinesin-like protein KIF11 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1056 a.a.
335 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Bioorg Med Chem Lett
20:157-160
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.
|
|
P.A.Barsanti,
W.Wang,
Z.J.Ni,
D.Duhl,
N.Brammeier,
E.Martin,
D.Bussiere,
A.O.Walter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A series of tetrahydro-beta-carbolines were identified by HTS as inhibitors of
the kinesin Eg5. Molecular modeling and medicinal chemistry techniques were
employed to explore the SAR for this series with a focus of removing potential
metabolic liabilities and improving cellular potency.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Z.Chen,
R.Cao,
B.Shi,
W.Yi,
L.Yu,
H.Song,
and
Z.Ren
(2010).
Synthesis and biological evaluation of novel beta-carbolines as potent cytotoxic and DNA intercalating agents.
|
| |
Chem Pharm Bull (Tokyo),
58,
901-907.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |